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1. Introduction 
Signal transduction is defined as the transfer of a signal starting from a primary messenger 
with a ligand that binds to specific receptors on the cell membrane. The signal then reaches 
the effector molecule(s) through a cascade involving various protein kinases and/or protein 
phosphatases as well as other molecules such as adaptor proteins, anchoring proteins, 
amplifier proteins, etc. Although erythrocytes are nucleus-free cells, they use elements of 
cell signal pathways that help them to maintain membrane integrity, ion transport, and 
metabolism. Aging, some “stress” conditions, and various diseases also may generate cell 
signals into erythrocytes (Minetti и Low, 1997; Antonelou et al. 2010; Berzosa et al. 2011; 
Pantaleo et al. 2010). Molecules from both erythrocyte membranes and from cytosol may 
take part in signal transduction. Membrane components involved in signal transduction 
include receptors, heterotrimeric G-proteins, adaptor and anchoring proteins, and some 
proteins of the Ras-superfamily. The еrythrocyte intracellular signaling cascade is divided 
into protein kinases and phosphatases, second messengers and small GTPases, which could 
further be defined as cell surface and intracellular activities (Pasini et al. 2006). In general, 
the mechanisms of signal transduction in erythrocytes can be summarized in the following 
groups: 1) specific mechanisms triggering changes in the activity of erythrocyte enzymes, 2) 
specific mechanisms inducing changes in the activity of transport systems, 3) signal 
transduction related to membrane association/dissociation of cytoskeletal and integral 
proteins, 4) "stressful" conditions may induce activation of specific cellular signals into 
erythrocytes. Phosphorylation of the erythrocyte proteins by protein kinases and 
phosphatases is the key mechanism for controlling erythrocyte functions. 
2. Binding of extracellular ligands to receptors on erythrocytes membrane 
initiates various processes of phosphorylation of erythrocyte proteins 
2.1 Thyroid stimulating hormone 
Thyroid stimulating hormone (TSH) binds to a specific TSH receptor (TSHR) which 
activates adenylate cyclase and increases cAMP levels in thyroid cells. Recent studies have 
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reported that TSHR and Na/K-ATPase are localized on the membranes of both erythrocytes 
and erythrocyte ghosts. TSHR responds to TSH treatment by increasing intracellular cAMP 
levels from two to tenfold. The authors suggest a novel cell signalling pathway, potentially 
active in local circulatory control (Balzan et al. 2009).  
2.2 Parathyroid hormone  
Parathyroid hormone (PTH) operates with G-protein dependent receptors and has been 
shown to decrease erythrocyte deformability in a Ca2+-dependent manner (Bogin et al. 
1986). In pseudohypoparathyroidism, PTH resistance results from impairment caused by a 
deficiency of Gsǂ-signaling cascade due to a metylation defect of the GNAS gene and 
decrease in erythrocyte Gsǂ activity (Zazo et al. 2011). 
2.3 Insulin  
Insulin stimulates erythrocyte glycolysis, Na+/H+-antiport and Na+/K+-ATPase (Rizvi et 
al.1994), as well as membrane-associated NO-synthase (Bhattacharaya al. 2001). It has been 
shown that insulin uses signaling pathways involving both ζ-PKC and phospatidylinositol 3 
kinase (PI3K), which leads to the activation of Na+/H+-antiports (Sauvage et al. 2000). 
Insulin is also used in the MAPK-signaling cascade of phosphorylation and activation of 
protein NHE1, responsible for Na+/H+ - antiport (Sartori et al. 1999). 
Participation of C-peptide in insulin signaling pathways has also been discussed, including 
involvement of G-protein and Ca-dependent phosphatase. It has been reported that insulin 
restores the activity of Na+/K +-ATPase (De La Tour et al. 1998). The decrease in Na+/K+ 
adenosine triphosphatase (ATPase) in erythrocytes of type 1 diabetes is thought to play a 
role in the development of long-term complication. Infusion of insulin may restore this 
enzyme activity in red cells (Djemli-Shipkolye et al. 2000). 
A reduced erythrocyte insulin receptor binding and tyrosine kinase activity was measured 
in hypertensive subjects with hyperinsulinemia (Corry et al. 2002). Erythrocytes from 
normal individuals showed increased pH and increased sodium influx (NHE1) after insulin 
stimulation. In contrast, insulin had no effect on NHE1 activity of eryhthrocyte from obese 
individuals (Kaloyianni et al. 2001). Insulin activation of insulin receptor kinase in 
erythrocytes is not altered in non-insulin-dependent diabetes and not influenced by 
hyperglycemia (Klein et al. 2000). 
2.4 Insulin-like growth factor I 
Erythrocytes possess receptors for insulin-like growth factor I (IGF-I). Binding to these 
receptors is dependent on cell age (Polychronakos et al. 1983). Acromegalic patients with 
higher plasma IGF-I and insulin levels presented lower IGF-I specific binding and affinity than 
normal adults. Growth hormone (GH)-deficient children showed higher IGF-I binding without 
significant affinity alterations than normal prepubertal children (el-Andere et al. 1995). 
2.5 Leptin 
The specific binding of leptin on erythrocytes is established by Scatchard analysis (Tsuda, 
2006). NHE1 (Na+/H+-exchanger) activity increases in the presence of leptin but significantly 
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less in the obese than in the control group. Since NHE1 activity is associated with insulin 
resistance and hypertension, the activation of this antiport by leptin may represent a link 
between adipose tissue hypertrophy and cardiovascular complication of obesity 
(Konstantinou-Tegou et al. 2001). It is possible to assume that leptin, similarly to insulin, 
might be able to activate NHE1 through MAPK activation (Sartori et al. 1999; Bianchini et al. 
1991). 
2.6 Adrenaline, Noradrenaline and DOPA 
The ǃ-2-adrenergic receptor coupled to the G-protein binds cateholamines and activates 
adenylate cyclase in human erythrocytes (Horga et al. 2000). The functional beta-receptor 
response depends to a large extent on Ca2+ concentrations (Horga et al. 2000). According to 
Muravyov et al. (2010) a crosstalk between adenylyl cyclase signaling pathway and Ca2+ 
regulatory mechanism exists. The potent beta-adrenergic agonist, isoproterenol (2 microM), 
epinephrine (10 microM) and norepinephrine (10 µM) stimulated the cAMP-dependent 
protein kinase in erythrocyte membranes, 38 +/- 7%, 31 +/- 6%, and 30 +/- 6%, respectively 
(Tsukamoto and Sonenberg, 1979). Micromolar concentration of noradrenaline (1 µM) 
increases the 32Ǿ intake in band 2 with 70%, and with 40% in band 3 (Nelson et al. 1979). 
Adrenaline and noradrenaline are both found to stimulate the erythrocyte Na+/H+-antiport 
(Perry et al. 1991; Paajaste and Nikinmar, 1991). Adrenaline stimulates Na+/H+-antiport 
through activation of NHE1 transport system with participation of ǾКǿ, since the effect has 
been reported to potentiate in the presence of phorbol ester (PKC activator), and being  
inhibited  from  calphostin (PKC inhibitor), respectively (Bourikas et al. 2003).  
A specific erythrocyte DOPA transport protein was found who is also capable to transports 
choline. Its functions are regulated by insulin (Azoui et al. 1996). 
Several catecholamines (phenylephrine, dobutamine and dopamine) inhibit the Cl-removal-
activated Ca2+ entry into erythrocytes, thus preventing increase of cytosolic Ca2+ activity, 
subsequent cell shrinkage and activation of erythrocyte scramblase. The catecholamines 
thus counteract erythrocyte phosphatidylserine exposure and subsequent clearance of 
erythrocytes from circulating blood (Lang et al. 2005). 
Exposure of RBCs to adrenaline resulted in a concentration-dependent increase in RBC 
filterability and authors supposed that adrenergic agonists may improve passage of 
erythrocytes through microvasculature (Muravyov et al. 2010). Rasmussen et al (1975) 
reported that the same low doses of adrenaline and isoproterenol induce a decrease of 
erythrocyte deformability.   
2.7 Adenosine 
Adenosine binds to the erythrocyte adenosine type1 receptors (A1AR) and adenosine type 2 
receptors (A2AR), (Lu et al. 2004; Zhang et al. 2011). A1ARs are functionally coupled with 
pertussis toxin-sensitive G proteins and inhibit the activity of adenylate cyclase. A1ARs bind 
to erythrocyte membrane cytoskeletal protein 4.1G, which can inhibit A1-receptor action (Lu 
et al. 2004). A1ARs activation can also trigger the release intercellular Ca2+ (Lu et al. 2004). 
Increased adenosine levels promoted sickling, hemolysis and damage to multiple tissues in 
SCD transgenic mice and promoted sickling of human erythrocytes. (Zhang et al. 2011). 
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2.8 Prostaglandins (PG) 
Binding of PGE2 to receptors coupled to the G-protein activates phospholipase C which in 
turn catalizes phospholipide turnover (Minetti et al. 1997) and/or stimulates a Ca2+-dependent 
K+ chanell in human erythrocytes and alters cell volume and filterability (Li et al. 1996). The 
PGE1 receptor coupled to the G-protein activates adenylate cyclase in human erythrocytes and 
increases erythrocyte deformality (Dutta-Roy et al. 1991). Prostacyclin (PGI) binding to human 
erythrocyte receptors stimulate cAMP synthesis and ATP release (Sprague et al. 2008). 
2.9 Thyroid and steroid hormones 
Lipophilic hormones take part in signal transduction also with "non-genomic" effects using 
signals starting from the plasma membrane (Falkenstein et al. 2000). Their role in 
erythrocyte signal transduction pathways and their activities have not been fully explored. 
Similar results have been reported for thyroid hormones (Angel et al.1989; Botta and Farias, 
1985), and for estrogens (Gonçalves et al. 2001). Effect of thyroid hormones is probably 
related to calmodulin-dependent activation of erythrocyte membrane ATPase (Lawrence et 
al. 1993), that is inhibited in the presence of retinoic acid (Smith et al. 1989).  
In vitro beta-estradiol 10-5 M decreased erythrocyte aggregation in blood samples of 
postmenopausal women undergoing hormone therapy, which could prevent high blood 
viscosity and, consequently, cardiovascular events (Gonçalves et al. 2001). 
Results from X-ray diffraction studies revealed that cortisol and estradiol bind into the 
erythrocyte membrane bilayer, and exert opposite effect over Na+/К+-АТPase activity: 
cortisol diminishes its activity by 24%, but estradiol increases it by 18% (Golden et al. 1999). 
Other published in vitro studies showed that aldosterone stimulates Na+/К+-АТPase activity 
in human erythrocyte membranes (Hamlyn and Duffy, 1978). One possible explanation is 
that the incorporation leads to conformational changes and reorganization in the active 
center of the enzyme molecule of Na+/K+-ATPase. In addition to the delayed genomic 
steroid actions, increasing evidence for rapid, nongenomic steroid effects has been 
demonstrated for virtually all groups of steroids, and transmission by so far hypothetical 
specific membrane receptors is very likely. Nongenomic effects on cellular function involve 
conventional second messenger cascades (Falkenstein et al., 2000). Plasma selenium as well 
as plasma and erythrocyte gluthatione peroxidase activity increase with estrogen during the 
menstrual cycle. The mechanism is still unknown (Ha and Smith, 2003). 
2.10 Cytokines 
Biochemical evidence is provided for the presence of endothelin (ET) receptor subtype B in 
syckle and normal red cells. It was found that ET-1, PAF (Platelet Activating Factor), 
RANTES and IL-10 induce a significant increase in red cell density. These data suggest that 
activation of the Gardos channel is functionally coupled to receptors as C-X-C(PAF), C-C 
(RANTES) and ET receptors type B and the cell volume regulation or erythrocyte 
hydratation state might be altered by activation of the Gardos channel by cytokine in vivo 
(Rivera et al. 2002). 
Human red cells bind specifically IL-8 (a neutrophil activating chemokine) with IL-8RA and 
IL-8RB receptors. Red cell absorbtion of IL-8 may function to limit stimulation of leucocytes 
www.intechopen.com
 
Protein Kinases and Protein Phosphatases as Participants in Signal Transduction of Erythrocytes 
 
253 
by IL-8 released into blood (Darbonne et al. 1991). IL-8 released after acute myocardial 
infarction is mainly bound to erythrocytes (de Winter et al. 1997).  
ICAM-4 belongs to the intercellular adhesion molecules and is an erythrocyte membrane 
component. ICAM-4 interacts specifically with platelet alphaIIbeta 3 integrin. RBCs are 
considerated passively entrapped in fibrin polymers during trombosis through ICAM-4 
(Hermand et al. 2003). 
2.11 Thrombin 
It is assumed that thrombin induces a signal that stimulates the formation of cAMP and 
PGE1 via activation of Gs-dependent adenylate cyclase and Ca2+-independent PKC in 
eryhtrocyte progenitors. Signaling pathway is inhibited by amiloride and by PKC inhibitors 
such as GF-109203X, Go 6976 and staurosporine (Haslauer et al. 1998). However, whether or 
not these signals are also valid for mature erythrocytes has not been studied yet. 
2.12 Lactoferrin 
Lactoferrin (Lf) is a metal-binding glycoprotein with antioxidative (Cohen et al., 1992), anti-
inflammatory, immunomodulatory (Legrand et al., 2004), anticancerogenic (Thotathil and 
Jameson, 2007) anti-bacterial (Weinberg, 2007), antiviral (Mistry et al., 2007), antiatherogenic 
(Kajikawa et al. 1994), and antithrombotic properties (Levy-Toledano et al., 1995).  
Our previous studies showed that Lf binding with erythrocyte membrane receptors (Taleva 
et al., 1999) results in stimulation of glycolysis, antioxidative protection (Maneva et al., 2003) 
and activation of Na+/K+-ATPase activity (Maneva et al., 2007). Lf–receptor interaction 
might intervene in short–term effects of regulation, involving processes of changes in 
association, phosphorylation and oxidation of the membrane proteins.  
Lf (10-50 nM) decreased the ATP content from 9 to 57% depending on the concentration 
used. There is a negative correlation found between the concentration of added Lf and 
formed ATP: y = 2.550 - 0.0076.x, r = - 0.993, p <0.001, n = 5 (Figure 1). The reason for the 
decrease of ATP in the presence of Lf could be the processes of phosphorylation and/or ion 
transport activated by Lf. Lf is an activator of protein phosphorylation (Maekawa et al. 2002; 
Curran et al. 2006) and an activator of  ion transport (Sun et al. 1991). Such a decrease in 
ATP content was found by other authors (Assouline-Cohen and Beitner, 1999; Boadu & 
Sager, 2000) due to stimulation of vital processes of erythrocytes.  
Lf could stimulate glycolysis by interfering with phosphorylation processes: 1) There is 
evidence that insulin activates the Na+/H+ - antiport in erythrocytes by PI3K-dependent 
signaling pathway (Sauvage et al. 2000) leading to activation of glycolysis (Madshus, 1988). 
Like insulin, Lf also activates Na+/H+ - antiport (Sun et al. 1991) and stimulates the lactate 
formation (Maneva et al. 2003). Therefore, it could be suggested that Lf uses the same PI3K - 
dependent mechanism for glycolysis activation (Boivin, 1988); 2) Phosphorylation of tyrosin 
residues in band 3 (Boivin, 1988) leads to dissociation of the complex with glycolytic 
enzymes, leading to their activation (Low et al. 1993). Lf could also stimulate the glycolytic 
enzymes by activating Src-kinase-dependent phosphorylation of band 3. There is data 
showing that Lf is an activator of tyrosine phosphorylation by Src-kinases (Takayama & 
Mizumachi, 2001). 
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Fig. 1. Correlation and regression analysis of the relation between the concentration of Lf 
and content in erythrocyte ATP (unpublished data).  
Sigma-Aldrich test kit has been used in this experiment. The method is based on using a 
reaction from oxidative phosphorylation (OP) in glycolysis where ATP is produced. OP is 
two–stage process involving the enzymes glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), and 3-phosphoglycerate kinase. The output products of OP are 3-
phosphoglycerate, NADH+ and ATP. The test uses GAPDH in reverse direction: a 
conversion of 1,3 bisphosphoglycerate into glyceraldehyde-3-phosphate, where the 
oxidation of NADH+ to NAD+ is directly proportional to the amounts of the ATP produced. 
The results are presented in µmols ATP/g.Hb.  
Several possible mechanisms could be discussed in regard to how Lf binding to the 
receptors on the erythrocyte membrane might lead to Na+/K+-ATǾase activation (Maneva 
al. 2007) via changes in levels of phosphorylation of membrane and cytosolic proteins: 1) 
Changes in the levels of phosphorylation of tyrosine residues in erythrocyte membrane 
modulates not only the activities of band 3 (Brunati et al. 2000), but  also the activity of  ǂ–
subunit of Na+/K+-ATǾase (Done et al. 2002). ǂ-subunit of Na+/K+-ATǾase is 
phosphorylated by tyrosine kinases, as the target of phosphorylation is known to be the 537 
tyrosne residue in the molecule. This phosphorylation is proved to be a prerequisite for the 
participation of Na+/K-ATǾase in signal transduction in experiments with renal cells (Done 
et al. 2002). Lf stimulates tyrosine phosphorylation of proteins (Takayama & Mizumachi, 
2001). 2) It is known that Lf activates casein kinase 2 (CK2), and is phosphorylated by the 
latter (Maеkawa et al. 2002). CK2 phosphorylates and activates a wide spectrum of 
erythrocyte membrane proteins associated in multiprotein complexes with  Na+/K+-ATǾase 
(Wei and Tao, 1993); 3) Non-receptor tyrosine kinase Src takes part in signal pathway that 
regulates Na-pump activity in other cell types (Haas et al. 2002). Lf is also able to activate 
Src (Takayama and Mizumashi, 2001). 4) Stimulating effect of Lf could be indirect as Lf 
activates Na+/H+ antiport (Sun et al. 1991). By this mechanism erythrocytes are loaded with 
Na+ thus activating Na+/K+-ATǾase which exports Na+ out of the erythrocyte cell.  
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2.13 Polyamines 
Membrane receptors for polyamines were proved to exist on erythrocyte membranes 
(Moulinoux et al. 1984). After binding with their receptors, polyamines enhance the protein–
protein interactions among the cytoskeletal proteins and membrane lipid bilayer (Bratton, 
1994; Farmer et al. 1985). Polyamine also inhibits transbilayer movement of plasma 
membrane phospholipids in the erythrocyte ghost (Bratton, 1994). 
Polyamines are CK2 protein kinase activators (Leroy et al.1997). It was found that positively 
charged betaine and polyamines inhibit the activity of membrane Na+/K+-АТPase in 
erythrocytes. It has been demonstrated that the effect of polyamines is based on the 
competitive inhibition mechanism (Kanbak et al. 2001). A similar mechanism is most likely 
responsible for the poor ion transport in cancer patients whose tumor cells secrete 
polyamines (Villano et al. 2001). Raised erythrocyte polyamine levels are estimated in 
patients with diabetes type 1 and in non-insulin dependent diabetes mellitus with great 
vessel disease and albuminuria (Seghieri et al. 1997). 
2.14 Caffeine 
Caffeine binds to erythrocytes membrane proteins (Sato et al. 1990) and could induce 
changes in the erythrocyte protein complex’s formation, thus modulating the activity of 
enzymes involved in signal transduction. Caffeine could interfere with the phosphorylation 
processes in erythrocytes as an inhibitor of erythrocyte CK2 (Lecomte et al. 1980), and PI3K 
(Buckley, 1977) as it was reported in other cell types. Methylxanthines are capable for 
inhibition of cyclin-dependent protein kinases found in both cytosol and erythrocyte 
membranes (Biovin, 1988). 
Processes of phosphorylation-dephosphorylation of erythrocyte membrane and plasma 
proteins provide different levels of interaction and participate in maintaining the integrity of 
the erythrocyte membrane. They also exert control over important metabolic processes in 
erythrocytes. The literature data shows that signals in erythrocytes lead to changes in 
phosphorylation and association of integral membrane proteins and other intracellular 
proteins. Cytosolic protein kinases and protein phosphatases were found in erythrocyte 
membrane.  
3. Protein kinases 
3.1 Protein serine/threonine kinases 
3.1.1 сАМР dependent protein kinases 
Type 1 isoform of cAMP dependent protein kinase is localized in the membrane, while type 
2 is located in the cytosol (Dreytuss et al. 1978). cAMP-protein kinases-dependent 
phosphorylation of isoforms of membrane Ca2+-ATPase was found. Isoform 1 is shown to 
be better substrate in comparison to isoforms 2 and 4. Isoform 1 is susceptible to 
degradation by calpain (thiol-dependent protease) (Guerini et al. 2003). 
In all cells, increasing in cAMP are regulated by the activity of phosphodiesterases (PDEs) 
(Sheppard and Tsien, 1975). In erythrocytes, activation of either beta adrenergic receptors 
(beta (2) AR) or the prostacyclin receptor (IPR) results in increases in cAMP and ATP release 
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(Sprague et al. 2001). Receptor-mediated increases in cAMP are tightly regulated by distinct 
PDEs associated with each signaling pathway, as shown by the finding that selective 
inhibitors of the PDEs localized to each pathway potentiate both increases in cAMP and 
ATP release (Adderley et al. 2010). 
Adenylyl cyclase and cAMP are components of a signal-transduction pathway relating red 
blood cells (RBC) deformation to ATP release from human and rabbit RBCs (Sprague et al. 
2008). Exposure of RBC to catecholamines (epinephrine, phenylephrine, an agonist of ǂ1-
adrenergic receptors, clonidine, an agonist of ǂ2-adrenergic receptors and isoproterenol, an 
agonist of ǃ-adrenergic receptors) led to change in the RBC microrheological properties. 
Forskolin (10 µM), an adenylate cyclase stimulator, increases the RBC deformability (RBCD). A 
somewhat more significant deformability rise appeares after RBC incubation with dibutyril-
AMP. Red blood cell aggregation (RBCA) is significantly decreased under these conditions. 
All drugs having PDE inhibitory activity increase red cell deformability (Muravyov et al. 
2009).  
Ca2+ entry increase is accompanied by red cell aggregation rise, while adenylyl cyclase-
cAMP system stimulation led to red cell deformability increase and its aggregation lowered. 
The crosstalk between two intracellular signaling systems is probably connected with 
phosphodiesterase activity. It was found that all four PDE inhibitors: IBMX, vinpocetine, 
rolipram, pentoxifylline decreased red cell aggregation significantly and, quite the contrary, 
they increased red cell deformability (Muravyov et al. 2010) 
Erythrocytes are oxygen sensors and modulators of vascular tone (Ellsworth et al. 2009). It 
has become evident that erythrocytes participate in the regulation of vascular caliber in the 
microcirculation via release of the potent vasodilator, adenosine triphosphate (ATP). The 
regulated release of ATP from erythrocytes occurs via a defined signaling pathway and 
requires increases in cyclic 3',5'- adenosine monophosphate (cAMP) (Adderley et al. 2010) . 
Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release 
from erythrocytes (Olearczyk et al. 2010). Insulin inhibits human erythrocyte cAMP 
accumulation and ATP release. The targets of insulin action are phosphodiesterase 3 and 
phosphoinositide 3-kinase (Hanson et al. 2010). TSH signalling pathway is cAMP-dependent 
and probably it is potentially active in local circulatory control (Balzan et al. 2009). 
3.1.2 cGMP-pependent protein kinases 
Petrov et al. (1994) supposed that human erythrocytes possess membrane and soluble 
guanylate-cyclase activity stimulated by atrial natriuretic peptide III (ANP-III) and that 
activation of Na+/H+ exchange by this peptide is mediated by cGMP (Petrov and Lijnen, 
1996). There are no reported data considering participation of protein kinases and 
phosphatases in the signal pathway.  
3.1.3 Casein kinase 1 and 2 
Membrane proteins of human erythrocytes can be phosphorylated not only by membrane 
casein kinase but also by cytosolic casein kinases, resembling casein kinase 1 and 2 (CK1 and 
CK2), respectively. CK1 and CK2 phosphorylate serine and threonine residues in target 
proteins (Boivin, 1988). CK2 inactivation mediated by phosphatidylinositol-4, 5-bisphosphate, 
a substrate for phospholipase C which catalyzes formation of lipid mediators IP3 and DAG 
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(Chauhan et al. 1993) has been found. It was established that CK2 is inactivated by insulin 
(Sommerson et al. 1987).  
An increased phosphorylation of the membrane proteins, promoted by the okadaic acid 
(strong inhibitor of P-Ser/Thr-protein phosphatase(s)), is accompanied by a release of CK 
from the membrane into the cytosol. Such an intracellular translocation might provide a 
feedback mechanism for the regulation of the CK catalyzed phosphorylation of membrane 
proteins in human erythrocytes (Bordin et al. 1994). 
The membrane mechanical stability of erythrocytes is exclusively regulated by 
phosphorylation of ǃ-spectrin by membrane bound CK1. Increased phosphorylation of ǃ-
spectrin decreased membrane mechanical stability while decreased phosphorylation 
increased membrane mechanical stability (Manno et al. 1995). 
CK2 isolated from erythrocyte membrane and cytosolic fractions exhibited the same subunit 
composition (ǂǂ1) and the ability to utilize ATP and GTP as phosphate donors. Both kinases 
were found to catalize the phosphorylation of several erythrocyte membrane cytoskeletal 
proteins (spectrin, ankyrin, adductin, protein 4.1 and protein 4.9). Unlike CK1, CK2 did not 
phosphorylate band 3. Spermine, spermidine, and putrescine stimulated to varying degrees 
the activities of erythrocyte CK2, whereas heparin inhibited the kinase activities (Wei and 
Tao, 1993).  
The phosphorylation sites of calmodulin are important for its ability to activate the human 
erythrocyte Ca2+-ATPase. Phosphorylation of mammalian calmodulin on serine/threonine 
residues by casein kinase 2 decreased its affinity for Ca 2+-ATPase by two fold. In contrast, 
tyrosine phosphorylation of calmodulin by the insulin-receptor kinase did not significantly 
alter calmodulin-stimulated Ca2+-ATPase activity (Sacks et al. 1996). 
The COP9 signalosome (CSN) is a multimeric complex that is conserved from yeast to man 
(Bech-Otschir et al., 2002). Immunoprecipitation and far-western blots reveal that CK2 and 
PKD are associated with CSN. The COP9 signalosome (CSN) purified from human 
erythrocytes possesses kinase activity that phosphorylates proteins such as c-Jun and p53 
with consequence for their ubiquitin (Ub)-dependent degradation. (Uhle et al., 2003)  
3.1.4 MAPK (Mitogen Activated Protein Kinases)  
It is well known that signaling pathways involving MAPKs are associated with control of 
cell growth and proliferation, but erythrocytes are mature highly differentiated cells. There 
are only a few known participants in the MARK-signaling pathways so far. Immunoblot 
with antiMAPK antibody revealed the two erythrocyte forms of MAPK–p44 (ERK1) and p42 
(ERK2). Insulin and okadaic acid (inhibitor of serine/threonine protein phosphatases) 
stimulate MAPK activity. Insulin enhances the erythrocyte Na+/H+-exchanger through 
MAPK activation (Sartori et al. 1999; Bianchini et al. 1991). Membranes of human erythrocytes 
contain several proteins of the Ras superfamily (Ikeda et al. 1988; Damonte et al. 1990). One 
of them, RhoA, was detected in both cytosol and membrane fraction of the erythrocytes. 
Cytosolic Rho bound specifcally to the cytoplasmic surface of the erythrocyte membrane. 
The translocation of Rho to the membrane was absolutely GTP -dependent at low Mg2+ 
concentration (Boukharov et al. 1998). 
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3.2 Protein tyrosine kinases 
Erythrocyte membrane associated tyrosine kinase activity has been established (Zylinska et 
al. 2002), together with surprisingly high levels of phosphorylated tyrosine in erythrocytes 
(Phan-Dinh-Tuy et al. 1983).  
Two tyrosine kinases that are able to phosphorylate band 3 have been found. Involvement 
of the Src-kinases family in regulation of erythrocyte membrane transport has been 
suggested. That family represents an important class of non-receptor protein kinases 
participating in the regulation of cell communications, proliferation, differentiation, 
migration and survival (Minetti et al. 2004). Subsequent two-stage phosphorylation of band-
3 from Syk- and Lyn-tyrosin kinase was found. (Brunati et al. 2000). 
3.3 Ca
2+
 dependent phosphorylation 
Since mature RBCs lack intracellular calcium stores, elevation in intracellular calcium must 
stem from calcium influx. At low intracellular Ca2+, efflux of potassium and water 
predominates, leading to changes in erythrocyte rheology (Andrews et al. 2002). At higher 
Ca2+ content, activation of kinases and phosphatases was observed (Minetti et al.1996; 
Cohen and Gascard, 1992). Ca2+ ions are involved in regulation of phospholipase C, the 
enzyme generating inositol-1,4,5-triphosphate (InsP3), phosphatidylinositol-3-kinase (PI3K), 
the enzyme metabolizing InsP3 to InsP4 and in the regulation of protein kinase C (Carafoli, 
1994; Carafoli, 2002). 
3.3.1 Protein kinase C (PKC) 
There are four isoforms of PKC established in the erythrocyte: ǂ, ζ, ι and μ (PKD) (Govekar 
and Zingle, 2001). PKǿ translocates from cytosol to membrane – a process shown to be 
initiated by phorbol esters and diacylglycerols (Cohen and Foley, 1986). PKD and CK2 are 
associated with COP9 signalosome (CSN) (Uhle et al., 2003). 
PKC phosphorylates serine residues in band 3, band 4.1 and band 4.8 (Govekar and Zingle, 
2001). It has been reported that after stimulation with phorbol ester (PMA), ǾКǿ-ǂ 
translocates towards the erythrocyte membrane (Govekar and Zingde, 2001), where it 
phosphorylates serine residues in band 2, and 4.1 and band 4.9 which in turn leads to 
thorough rearrangement of the cytoskeleton membrane network (Giraud et al. 1988; 
Ceolotto et al. 1998). ǾКǿ phosphorylates membrane Na+/K+-АТPase (Wright et al. 1993) 
and the carboxyl terminus of the plasma membrane Ca2+-ATPase in human erythrocytes 
(Wang et al. 1991; Wright et al.1993; Smallwood et al.1988) and the effect of phosphorylation 
on the activity of the both enzymes depends on the isoenzyme form of protein kinase C.  
The interactions between membrane, peripheral and cytoskeleton proteins are responsible 
for the maintenance of erythrocyte deformability and some of these interactions are 
modulated by PKC activity. Correlation was established between cytoskeleton proteins, 
PKC activity, band 3 phosphorylation degrees and erythrocyte deformability (de Oliveira et 
al. 2008). PKC participates in the processes of phosphorylation of band 3 that regulates its 
activity as a transport protein (Ceolotto et al. 1998). Protein kinase C mediates erythrocyte 
"programmed cell death" following glucose depletion (Klarl et al. 2006). 
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In erythrocytes, lead acetate stimulates the phosphorylation of membrane cytoskeletal 
proteins by a mechanism dependent on protein kinase C. Since levels of calcium or 
diacylglycerols did not increase, it appears that lead may activate the enzyme by a direct 
interaction (Belloni-Olivi et al. 1996). 
Calpain is a ǿа2+-dependent thiol protease that translocates towards the erythrocytes 
membrane and activates with increase of intracellular calcium concentration (Glasser et al. 
1994). Calmodulin binds proteins as calpain substrates (Wang et al. 1989). It is known that 
calpain causes transition from ǿа2+-dependent ǾКǿ form to Ca2+-independent one, followed 
by decrease in its activity (Saido et al. 1994).  
3.3.2 Calmodulin (CaM)  
The increase in cellular Ca2+ results in reversible formation of Ca2+/CaM complex that binds 
to a number of enzymes modulating their activity (Carafoli, 2002).   
Calmodulin is a ubiquitous protein whose activity is regulated through phosphorylation 
and specific Ca2+-binding (Benaim and Villalobo, 2002). Ca2+-ATPase interacts with the 
carboxy-terminal half of calmodulin, which is the region that contains the majority of the 
phosphorylation sites in calmodulin (Bzdega and Kosk-Kosicka, 1992). ǿаǺ is 
phosphorylated by serine/threonine kinases such as CK2 and PKA (Benaim and Villalobo, 
2002). Phosphorylation of a tyrosine residue in CaM (Tyr99) increases the affinity of its 
binding to the target proteins thus increasing their activity. A similar stimulating effect of 
CaM has been reported for Ca2+-ATPase (Kosk-Kosicka et al. 1990), myosin light chain 
kinase (MLCK), Ca-CaM dependent kinase (CaM kinase II) and Ca-CaM dependent protein 
phosphatase 2B (calcineurin) (Corti et al. 1999). Elevated intracellular Ca2+, in association 
with the Ca2+-binding protein, calmodulin, stimulates erythrocytes phosphofructokinase 
(PFK) activity. This activation involves the detachment of the enzyme from erythrocyte 
membranes, which has been described as an important mechanism of glycolysis regulation 
on these cells (Zancan and Sola-Penna, 2005).  
ǿаǺ is an inhibitor of ǾІ3Ǿ-kinase (Villalonga et al. 2002), Na+/H+ antiport (Yingst et al. 
1992) and of erythrocyte Na+/K+-ATPase (Yingst at al. 1992). The latter effect could be 
exerted via inducing of signal pathway involving CaM-dependent kinase that activates 
membrane phospholipase A2(PLA2), which in turn inhibits Na-pump (Okafor et al. 1997).  
4. Protein phosphatases 
Erythrocyte phosphatases that dephosphorylate phosphoserine, phosphothreonine and 
phosphotyrosine residues in different proteins were found. Cytoplasmic phosphatases, low-
molecular-weight acid phosphatases, and neutral membrane-associated tyrosine 
phosphatases have been reported (Clari et al. 1987; Graham et al. 1974).  
Protein phosphatases originated from two ancestor genes, one serving as the prototype for 
the phosphotyrosine phosphatases family (the PTP family), and the other for 
phosphoserine/phosphothreonine phosphatases (the PPP and PPM family). The PPP family 
groups the PP1, PP2, PP2B, PP4, PP5, PP6 and PP7 enzymes, whereas PP2C and bacterial 
enzymes like SpoII or PrpC belong to the PPM family (Batford, 1996; Kiener et al. 1987). 
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Band 3 is a target for tyrosine phosphatases SHǾ-1 and SHP-2 (Bordin et al. 2002) and PTP1B 
activities (Zipser and Kosower, 1996). Ca2+ promotes erythrocyte band 3 phosphorylation 
via dissociation of phosphotyrosine phosphatase from band 3 (Ziper et al. 2002) 
SHP-2 is an essential soluble protein tyrosine phosphatase (PTP) containing two spectrin 
homologous domains - SH2. SHR-2 domain participates in multiple signaling pathways of 
growth factors (GF) and cytokines, and plays an important role in the release of signals from 
the cell surface to the nucleus. SH2 is the anchor (docking) place where the protein tyrosine 
kinases, e.g. Src family are attracted to and attached to, thus facilitating phosphorylation-
dephosphorylation cycle. SHR-2 is located in the erythrocytes cytosol and it is translocated 
to the erythrocyte membrane when there is increased tyrosine phosphorylation of the 
transmembrane protein band 3, induced by PTP inhibitors such as pervanadate, and  
N-ethylmaleimide. Band 3 is both anchoring protein and substrate for the SHP-2 (Bordin et 
al. 2002). SHǾ-1 and SHǾ-2 ensure dephosphorylation of band 3 in different conditions: 
SHǾ-2 through interaction of its SH2 domain(s) to p-tyr protein is regulated by the band 3 
tyr-phosphorylation level; SHǾ-1 dephosphorylates tyr-8, tyr-21 and tyr-904 and may be 
involved by simple membrane rearrangement (Bragadin et al. 2007). 
Protein phosphatase-1 ǂ (PP1alpha) is a selective substrate of peroxynitrite activated src family 
kinase frg and tyrosine phosphorylation of PP1alpha correspond to inhibition of its enzyme 
activity. The final effect of peroxynitrite is the ampliphication of tyrosine dependent signaling, 
a finding of general interest in nitrite oxide related pathophysiology (Mallozzi  et al. 2005) 
ǾТǾ1В is localized at the erythrocyte membrane associated with band 3. It is activated by 
Mg2+ and inhibited by Mn2+ and vanadate ions (VO3-), (Zipser  and Kosower, 1996). PTP1B, 
unlike the other enzymes examined, was quantitatively conserved during erythrocyte aging 
(Minetti et al. 2004) and erythrocytes may undergo in vivo activation of the Ca2+-dependent 
calpain system that proteolytically regulates PTP1B activity (Ciana et al. 2004). 
The activities of Na+/H+ exchanger and Na-K-2Cl cotransporter in rat erythrocytes are 
regulated by protein phosphatases PP1 and PP2 and stimulated when protein 
dephosphorylation is inhibited (Ivanova et al. 2006). 
5. Control over glycolytic enzymes 
Glycolytic erythrocyte enzymes that form a complex with band 3 are under regulation by 
the processes of phosphorylation and oxidation (Campanella et al. 2005), and pyruvate 
kinase (PK) - by phosphorylation/dephosphorylation (Kiner and Westhead, 1980). Binding 
of phosphofructokinase (PPK), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 
aldolase to band 3 lead to their reversible inhibition (Low et al. 1993),   which is neutralized 
by tyrosine kinase phosphorylation of band 3 resulting in enzymes activation. (Harrison et 
al. 1991). Ȟ72syk and p56/53lyn tyrosine kinases are also involved in band 3 phosphorylation 
(Hubert et al. 2000), and phosphorylation/dephosphorylation cycle is maintained by protein 
phosphatases ǾТǾ1В and SHP-2 (Bordin  et al. 2002; Zipser and Kosower, 1996; Minetti et  
al. 2004).  
PK turns to an inactive form after phosphorylation by ȟАǺǾ-dependent protein kinase, 
though it is unclear why since erythrocytes do not undergo gluconeogenesis. ǾК is activated 
by erythrocyte protein phosphatases (Kiener and Weathead, 1980).  
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ǿаǺ induces dimerisation of phosphofructokinase (PFK) and physiological levels of 
concentration of intracellular Ca2+ stimulates its catalytic activity (Marinho-Carvalho et al., 
2006). However, results obtained from other authors showed that Ca2+/calmodulin protein 
kinase (CaM-kinase) phosphorylation inhibits phosphofructokinase (PFK) in sheep heart 
(Mahrenholz et al. 1991) 
Ferricyanide activates glycolysis in erythrocytes in two ways. Ferricyanide is the only 
known non-physiological extracellular agent who induces signal transduction leading to 
activation of cytoplasmic protein tyrosin kinase  that phosphorylates enzyme-binding site in 
band 3, which in turn leads to release and activation of glycolytic enzymes GAPDH 
(glyceraldehyde-3-phosphate-dehydrogenase), PPК (phosphofructokinase) and aldolase 
(Low at al. 1990). It is proved that ferricyanide is a stimulator of glycolysis as end acceptor 
of electrons produced in glyceraldehyde-3-phosphate dehydrogenase reaction. Thus, 
ferricyanide is capable of recovering the level of oxidated NAD+ which is important for 
maintaining the rate of glycolysis (Orringer and Roer, 1979). There are experiment-based 
evidence for the existence of erythrocyte e- transport transmembrane chain related to 
transferrin receptor (Orringer and Roer, 1979; Goldenberg et al. 1990), that is known to 
reduce K3Fe(CN)6 and removes protons from inside the cell through the cell membrane 
(Low et al. 1987). Our own experiments showed that K3Fe(CN)6 inhibits 59FeLF binding to 
erythrocytes (Maneva et al. 2003) as most probably Lf and K3Fe(CN)6 compete for one and 
the same electron formed in oxidative phosphorylation in glycolysis; Lf is the physisological 
activator of the signal pathway used by ferricyanide that leads to tyrosine phosphorylation 
of band 3 and consequent glycolysis activation. 
6. Modulation of components of erythrocyte membrane skeleton  
In terms of proteins, the RBC membrane is a complex network of transporters, cytoskeletal 
molecules, and membrane-bound enzymes. The ability of transmembrane receptor proteins 
to change their cytoskeleton associations in response to ligand binding looks like a key 
mechanism for cell signaling through erythrocyte membrane. The erythrocyte membrane 
skeleton has 3 main components: spectrin molecules forming tetramers ǂ2ǃ2, short actin 
oligomers containing 12-15 monomers, and band 4.1. A variety of membrane-associated 
enzymes, including several kinases (protein kinase A, protein kinase C, cdc kinase, casein 
kinase 1) are thought to regulate interactions within the network through induction of 
phosphorylation, methylation, myristoylation, palmytoylation, or farnesylation (Pasini et  
al. 2010). 
Spectrin binding to actin is initiated from aductin and is significantly inhibited in the 
presence of ǿа2+ and ǿаǺ. ǿаǺ is able to form weak bonds with spectrine and in the 
presence of ǿа2+ could influence binding of protein 4.1 to actin, and probably spectrin 
phosphorylation as well (Manno et al. 1995).  
Band 4.1 is mainly involved in membrane skeleton organization due to its ability to initiates 
spectrin/actin association. Band 4.1 binds to the membrane in at least two sites: one high 
affinity site localized on glycophorins, and another low-affinity site associated with band 3. 
Phosphorylation of Band 4.1 by ǾКǿ was found to modulate its binding to band 3. Most 
probably, this increases the flexibility of the membrane in response to mechanical stress  
as was reported for some other models where the elevated levels of membrane 
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phosphorylation made cells more deformable and more resistant to mechanical stress 
(Danilov and Cohen, 1989). Association of band 4.1 with glycophorin is important for the 
maintenance of cell shape and is regulatated by polyphosphoinositide co-factor. Indeed, 
when a change in erythrocyte shape was found, a change in the phosphoinositide content 
was also found (Danilov et al. 1990). Band 4.1 phosphorylation regulates the assembling of 
spectrin, actin, and band 4.1 as phosphorylation diminish affinity of band 4.1 to spectrin. 
Band 4.1 and band 4.9 could be phosphorylated in different sites by ǾКǿ and by ȟАǺǾ-
dependent protein kinases (Horne et al.1990).  
Cytoskeletal protein band 4.1G binds to the third intercellular loop of the A1 adenosine 
receptor and inhibits receptor action. (Lu et al., 2004)  
7. Modulation of band 3 
The two most important integral proteins in human erythrocyte memranes are glycophorin 
A and band 3. Вand 3 is multifunctional protein whose N- and C-ends are localized on the 
cytoplasmic surface of the membrane and crosses the cell membrane 14 times. The ǿ-
terminal end is 52 kD domain (residues from 360 to 919) of band 3 and is responsible for 
anion transport through the membrane, while 40 kD from N-terminal end of the cytosolic 
domain plays a critical role in the binding of bilayer to spectrin-based skeletal net. 
Cytoplasmic domain of band 3 serves as a center of membrane organization, interacting 
with proteins, such as ankyrin, protein 4.1 and 4.4, hemoglobin, some glycolytic enzymes, 
tyrosine phosphatases, tyrosine kinase p72 (syk), and Na+/K+ - АТǾase. There are about 1 
million copies of band 3 per cell and they are presented as dimeric and tetrameric forms. 
Approximately 40-60% of band 3 is associated with spectrin-stabilizing cytoskeleton (van 
den Akker et al. 2010).  
Band 3 (АЕ1) is a member of the family of anion-transportng proteins that maintain Cl-
/HCO3 – exchange. It refers mainly to erythtocytes and plays a role in ǿǼ2 transport among 
the tissues and lungs (Saldanha et al. 2007). Erythrocyte PKC phosphorylates serine residues 
in band 3 (Govekar and Zingle, 2001). 
Band 3 modifications normally occur during physiological red blood cell (RBC) senescence 
and some pathological condition in humans (Santos-Silva et al. 1998). Вand 3-tyrosine 
phosphorylation might be induce in “stress” conditions: “oxidative stress”,  inhibition of the 
phosphoprotein phosphatase activity by vanadate or by thiol group blockers (diamide, N-
ethylmaleimide, etc.), protein tyrosine kinase (ǾТК) activation from hypertonic NaCl 
solution, or by intracellular increase of  Ca2+ levels (Hecht & Zick, 1992). Erythrocyte thiol 
status is an intrinsic regulator of phospho tyrosine residues levels in band 3 by 
oxidation/reduction of band 3–associated phosphotyrosine protein phosphatases (PTP) 
(Zipser et al. 1997). It is considered that the increase in phosphorylation induced by ǿа2+ 
ions, and including significant inhibition of PTP activity by dissociation of PTPase from 
band 3 may also play an important part in signal transduction pathways in some 
pathophysiological conditions accompanied with increased levels of intracellular Ca2+ 
(Minetti and Low, 1997).  
Abnormal band 3 tyrosine phosphorylation has been observed in a number of red cell 
disorders (Terra et al. 1998). Hyper-phosphorylated band 3 showed a manifest tendency to 
cluster, indicating a change in its interactions with the cytoskeletal network. Irreversible 
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band 3 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red 
cells. Syk kinase inhibition largely prevents red cell membrane lysis and vesiculation, 
strongly suggesting a functional role of band 3 tyrosine phosphorylation in the red cell 
membrane destabilization (Pantaleo et al. 2011; Bordin et al. 2005). 
Based on similarity in oligosaccharide components of band 3 and Lf (Ando et al. 1996), a 
competition for binding sites could be assumed (Beppu et al. 2000; Eda et al. 1996) together 
with restructuring of already established complexes. Our experiments revealed that Lf 
activates erythrocyte glycolysis (Maneva et al. 2003). This fact might be explained with some 
conformational changes leading to the release of glycolytic enzymes from their complex 
with band 3. Studies of the same investigators show that Lf, and erythrocyte band 3 occupy 
the same places on monocyte leukemic cell line THP-1 (Eda et al. 1996). Lf could also 
activate tyrosine phosphorylation of band 3 since Lf is already proved to be able to increase 
tyrosine phosphorylation of membrane proteins (Tanata et al. 1998).  
8. Changes in phosphorylation in oxidative stress  
The alteration of red cell thiol status affects the cell phosphotyrosine status and oxidative 
stress involves inhibition of PTP. Erythrocyte thiol alkylation by N-ethylmaleimide results 
in irreversible PTP inhibition and irreversible phosphorylation (Zipser et al. 1997). 
Oxidation of erythrocyte membrane by diamide leads to formation of disulfide bonds and 
following conformational changes in band 3. Most probably those changes lead to the 
opening of cryptic sites that become accessible for the binding of anti-band 3 antibodies 
(Turrini et al. 1994). Macrophages recognize oxidatively damaged autologous erythrocytes, 
and cell surface fibronectin of macrophages enhances the recognition (Beppu et al. 1991). 
Ca2+ signaling including Ca2+ influx, calmodulin activation, and myosin light chain 
phosphorylation are involved in the fibronectin stimulation of the recognition of 
macrophages for oxidized erythrocytes (Beppu et al. 2000). 
Pervanadate, N-ethylmaleimide and diamide strongly increase the two-stage 
phosphorylation of tyrosine residues of band 3 by Syk-kinase and Src-family (probably Lyn-
kinase). An intriguing fact is that there are different mechanisms by which osmotic and 
oxidative stress activate PTK Syk: oxidative stress leads to autophosphorylation, but osmotic 
one-to SH-2 domain phosphorylation. It was demonstrated that the same agents strongly 
enhance interaction between SHP-2 and band 3, which take part simultaneously with the 
translocation of this phosphatase from cytosol to erythrocyte membrane. These events are 
most likely mediated by Src-phosphorylation, since both translocation of SHP-2 and 
phospatase interaction with the erythrocyte membrane are prevented by ǾǾ2, a specific Src 
inhibitor. SHP-2 binds to band 3 via its SH2 region(s). Authors suggest that the attraction of 
cytosolic SHP-2 to band 3 preceeds the next dephosphorylation of the transmembrane 
protein (Bordin et al. 2002).  
Peroxynitrite (ONOO.) is a product of the reaction of nitric oxide and superoxide anion. It is 
able to nitrate protein tyrosine. If this modification occurs on phosphotyrosine kinase, 
substrates can down-regulate cell signaling. ONOO. at low concentrations is a stimulator of 
both band 3 tyrosine phosphorylation and erythrocyte glycolysis, but  higher  concentratons 
ONOO. induces cross-linking of membrane proteins, inhibition of  band 3 phosphorylation, 
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nitration of tyrosines in cytosolic domain of band 3, and irreversible inhibition of lactate 
production (Mallozi  et al. 1997). 
Deoxygenation and increase in intracellular Mg2+ content induce phosphorylation of 
tyrosine residues in human erythrocytes (Barbul et al. 1999).  
Increasing in erythrocyte volume is combined with stimulation in the activities of the two 
PTK- Ȟ72 (syk) and Ȟ56 (lyn) that phosphorylate band 3 (Musch et al. 1999).  
Oxidation of methionine residues in CaM prevents its activating effect on membrane ǿа2+-
АТPase (Gaop et al. 2001).  
The erythrocyte has a pool of flavonic compounds, which are considered a buffer, 
maintaining the antioxidative activity of the erythrocyte (Fiorani et al., 2003) Quercetin and 
resveratrol (piceatannol) take part in the regulation of the phosphorylation of band 3 in the 
presence of the physiological oxidant peroxinitrite. Quercetin decreases the Syk activity and 
particularly prevents mediated by the free radical peroxynitrite (ONOO.) phosphotyrosine 
phosphatase inhibition. Restraverol (whose anlogue is piceatannol) has another mechanism 
of action – it enables the mediated by peroxynitrite stimulation of tyrosine phosphorylation 
by another phosphotyrosine protein kinase – Lyn (Maccaglia et al., 2003). 
Pleiotropic effects of resveratrol include antioxidant activity and inhibition of 
cyclooxygenase with decrease of PGE(2) formation. In erythrocytes, oxidation and PGE(2) 
activate Ca2+-permeable cation channels. The Ca2+-entry leads to activation of Ca2+-sensitive 
K+channels with subsequent cell shrinkage and cell membrane scrambling with 
phosphatidylserine (PS) exposure at the erythrocyte surface. Cell shrinkage and 
phosphatidylserine exposure are hallmarks of suicidal erythrocyte death or eryptosis. 
Eryptotic cells adhere to the vascular wall, thus compromising microcirculation, and are 
cleared from circulating blood, thus leading to anemia. Resveratrol is a potent inhibitor of 
suicidal erythrocyte death during energy depletion, oxidative stress, and isoosmotic cell 
shrinkage. The nutrient could thus counteract anemia and impairment of microcirculation 
under conditions with excessive eryptosis (Qadri al. 2009). However, in some cases, 
flavonoids have been suggested to work as prooxidants (Kitagawa et al. 2004) 
9. Eryptosis (Apoptosis)  
Two signaling pathways converge to trigger apoptosis: (1) formation of PGE2 leads to 
activation of Ca2+-permeable cation channels; (2) the PLA2 (Phospholipase A 2) mediated 
release of PAF (platelet–activating factor) activates a sphingomielinase, leading to formation 
of ceramide. Increased cytosolic Ca2+ activity and enhanced cermide levels lead to 
membrane scrambling with subsequent PS exposure. Ca2+-activated Ca2+-sensitive K+ 
channels leading to cellular KCl loss and cell shrinkage. Ca2+ stimulates the protease calpain, 
resulting in degradation of cytoskeleton (Foller et al. 2008; Lang et al. 2010). 
Most triggers of eryptosis, except oxidative stress, are effective without activation of caspases. 
The involvement of Fas/caspase 8/caspase 3-dependent signaling in erythrocytes leads to PS 
externalization, a central feature of erythrophagocytosis and erythrocyte biology. The 
oxidatively stressed red cell recapitulated apoptotic events, including translocation of Fas into 
rafts, formation of a Fas-associated complex, and activation of caspases 8 and 3. The ROS 
(Radical Oxygen Species) scavenger N-acetylcysteine inhibits eryptosis (Mandal et al. 2005).  
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Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion 
(Klarl et al. 2006).  
Eryptosis is stimulated in a wide variety of diseases including sepsis, haemolytic uremic 
syndrome, malaria, sickle-cell anemia, beta-thalassemia, glucose-6-phosphate 
dehydrogenase (G6PD)-deficiency, phosphate depletion, iron deficiency, and Wilson's 
disease. Excessive eryptosis is observed in erythrocytes lacking the cGMP-dependent 
protein kinase-1 (cGK1) or cAMP activated protein kinase (AMPK). Moreover, eryptosis is 
elicited by osmotic shock, oxidative stress, and energy depletion, as well as a wide variety of 
endogenous mediators and xenobiotics. Inhibitors of eryptosis include erythropoietin, nitric 
oxide NO, catecholamines, and high concentrations of urea (Lang et al. 2006). 
10. Effect of modulators of phosphorylation on activity of erythrocyte 
glycolysis and sodium pump 
Modulation of cellular signals from other agents is a leading pharmaceutical approach for 
developing a therapeutic strategy for many diseases. Of significant practical importance is to 
address the right questions and to find the appropriate answers in regard to whether certain 
agents would exert synergic or opposite effects over key cellular functions.  
Erythrocyte membranes mediate the relation between ion transport and glycolysis. Na+/K+-
ATPase is not only transport system but also participates in ouabain – initiated signal 
transduction (Haas et al. 2002; Xie and Cai, 2003; Mohammadi et al.2001), and inititated cell 
signals in cardiac myocytes that are independent from changes of intracellular 
concentrations of Na+ and Ca2+ (Liu et al. 2000). It was demonstrated that glyceraldehyde-3-
phosphate-dehydrogenase interacts with cytoplasmic surface of Na+/K+-ATPase, and that 
interaction is shown to be inhibited by ouabain (Fossel and Solomon, 1978). The ǂ-subunit of 
Na+/K+-ATPase and band 3 form a heterodimeric structure (Martin and Sachs,. 1992). 
Similar structural integration allows shared control of both glycolysis and ion transport, and 
possible interference of modulators of ion transport in the control of glycolysis might be 
suggested (Fossel and Solomon, 1978). To verify our hypothesis we studied the effect of the 
same modulators of phosphorylation on both glycolysis (by measuring the amounts of its 
final product lactate) and Na+/K+-ATPase activity.  
10.1 Methods 
10.1.1 Isolation of the erythrocytes 
Heparinized fresh drawn blood from healthy donors was centrifuged at 2,000 ×g for 5 min 
at 4°C and the pellet was resuspended in 4 volumes of phosphate buffered saline (PBS) pH 
7.4. After three washes at 1,800, 1,500, 1,300 xg, the erythrocytes were isolated by density 
separation (Cohen et al., 1976). The erythrocyte fraction was resuspended in PBS pH 7.4 to 
obtain the same concentration as in the fresh blood. Cell concentration was counted in 
Burker’s camera by a Standard KF2 microscope (Carl Zeiss, Jena, Germany). The suspension 
did not contain other cell species. 
10.1.2 Preparation of the erythrocyte membranes 
Five milliliters of packed RBCs were mixed with 15 ml cold PBS (0.144 g/l KH2PO4.7H2O, 
9.0 g/l NaCl, and 0.795 g/l Na2HPO4.7H2O), pH 7.4, and centrifuged at 5,900 ×g for 10 min 
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at 4°C. The supernatant was discarded, and cells were washed with 15 ml cold PBS, 
centrifuged as above, and resuspended in 5 ml of 5 mM Na2HPO4, pH 8.0, for hypotonic cell 
lysis. Lysed cells were centrifuged at 25,000 ×g for 15 min at 4°C, after which the 
supernatant was gently aspirated and discarded. The RBC membrane pellet was repeatedly 
washed (4–5 times) with 5 mM Na2HPO4 until the pellet appeared white (indicating removal 
of Hb), and membranes were used for further experiments. The protein content of 
hemoglobin-free pellets was determined according to Bradford (1976), with human serum 
albumin as a calibrator. Samples were diluted to protein contents of 1.5 g/L. 
10.1.3 Hemoglobin measurement 
The hemoglobin (Hb) concentration of the erythrocyte suspension was determined 
according to Beutler (1975). 
10.1.4 Cell treatment 
The 50 µl erythrocyte suspension (2×107 cells/ml) was incubated 30 min at 25°C. Samples 
were performed in quadruplicates. In order to estimate the effect of cell signal modulators, 
samples were incubated either in the presence or in the absence of the agents.  
10.1.5 Chemicals 
All chemicals were purchased from Sigma-Aldrich Co, St Louis, MO USA. The mentioned 
below concentrations were chosen according the producer’s prescription and data existing 
in the literature about their optimal effect: Go6976 (50 nM) and Go6983 (50 nM) – inhibitors 
of protein serine kinase PKC. Go6976 is an inhibitor of the classic isoforms of PKC and PKD, 
while Go6983 inhibits only the classic isoforms. Both inhibitors were used simultaneously to 
exclude the effect of PKD; Caffeine (20 mM) was used as a phosphodiesterase inhibitor; 
Okadaic acid (20 nM) and Calyculin А (50 nM) as inhibitors of serine/treonine protein 
phosphatases; N-(6-Aminohexyl)-5-chloro-1-naphtalene-sulfonamide (W-7) (30 µM) as a 
calmodulin antagonist. 
10.1.6 Determination of lactate content in erythrocytes 
After centrifugation for 10 min at 2,000 ×g erythrocytes were resuspended in 0.4 ml 10% 
trichloroacetic acid (TCA). For obtaining of total  precipitation the samples were cooled on 
ice 10 min and then centrifuged again at the same conditions. 0.1 ml from the supernatant 
was used further according the prescription of the test kit reagent obtained from “SIGMA 
Diagnostics” (St. Louis, USA). The method was based on the reaction of pyruvate oxidation 
in the presence of NADH and lactate dehydrogenase. To estimate lactate, the reaction was 
carried out with excess NAD+ and the OD of NADH was measured at 340 nm. 
50 µl of erythrocyte suspension (2×107 cells/ml) was incubated for 30 min at 25°C in the 
presence (samples) or absence (control) of the chosen agents. After 10 min of centrifugation 
at 2,000 ×g, erythorcytes were resuspended in 0.4 ml of 10% TCA. For total sedimentation, 
erythrocytes were cooled down for 10 min and the centrifugation step was repeated at the 
same conditions. 0.1 ml from the supernatant was added to a preliminary prepared solution 
of NAD+ in 2.0 ml glycine buffer, 4.0 ml ddH2O and 0.1 ml lactate dehydrogenase. Instead of 
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supernatant, 0.1 ml 10% TCA was added as a blank. After 30 min of incubation at room 
temperature, the extinction was read at OD=340 nm. Results were calculated using a 
standart curve and equation according to kit instruction. Results were presented in μg/ml.  
10.1.7 Erythrocyte membrane ATPase activity 
Here, a method based on enzyme kinetics was used for evaluation of ATPase activity based 
on the amounts of generatated NAD+ in glycolytic reactions. The following reactions were 
explored: 1) conversion of phosphoenolpyruvate (PEP) to pyruvate and ATP by pyruvate 
kinase; 2) interconversion of pyruvate and lactate with concomitant interconversion of 
NADH and NAD+ catalyzed by lactate dehydrogenase (Vásárhelyi et al., 1997).  
Samples (50 µl) with protein concentration 1.5 g/l of erythrocytes membranes were added to 
450 µl of the following solution with final concentration per liter: 100 mmol of NaCl, 20 
mmol of KCl, 2.5 mmol of MgCl2, 0.5 mmol of EGTA, 50 mmol of Tris-HCl, pH 7.4, 1.0 mmol 
of ATP, 1.0 mmol of phosphoenolpyruvate, 0.16 mmol of NADH, 5 kU of pyruvate kinase, 
12 kU of lactate dehydrogenase (all purchased from Sigma). Finally, the tested modulators 
were added in the samples in above mentioned concentrations. After 5 min, 5 µl of 10 
mmol/l ouabain was added to inhibit the ouabain-sensitive ATPase activity. The change in 
absorbance was measured at OD=340 nm by a twin test (i.e., combination of two assays in 
one cuvette); Rate A (i.e., slope of total ATPase activity), 80–280 s; Rate B (i.e., slope of 
ouabain-resistant ATPase activity), 400–600 s. The difference between the two slopes was 
proportional to the Na+/K+-ATPase activity (Vásárhelyi et al. 1997). One unit of ATPase 
activity (1U) equals to one μmol oxidized NADH for 1 min. Calculations are based on the 
fact that NADH solutition with concentration 1 mg/ml has 0.80 extinction at OD=340 nm  
(E340 = 0.80) (Vásárhelyi et al. 1997). 
10.2 Results 
PKC inhibitors (Go6876 and Go6983), protein phosphatase inhibitors (OA and calyculin A), 
caffeine, and W-7 increased reliable lactate formation. Calyculin A  inhibits reliable Na+/K+-
ATPase (Table 1 and 2). From all studied modulators only Go6976 and Go6983, which are 
PKCs inhibitors, stimulated reliably Na+/K+-ATPase, with 194% and 84%, respectively 
(Table 1 and 2; Figure 2 and 3). 
 
Agents ( n = 6) 
Lactate μmol/g.Hb 
x ± SD 
p 
No agents (control) 5.15 ± 0.19 - 
Go6976 8.23 ± 0.63 <0.001 
Go6983 8.21 ± 3.24 <0.05 
Caffeine 8.07 ± 0.65 <0.001 
ǼA 7.84 ±  1.45 <0.001 
Calyculin A 7.23 ± 0.37 <0.001 
W-7 11.12 ± 0.30 <0.001 
Table 1. Effect of modulators of phosphorylation on lactate formation 
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10.3 Discussion 
10.3.1 Effect of PKC inhibitors 
Four isoforms of PKC in erythrocytes have been found: ǂ, ζ, ι and μ (PKD). Erythrocyte PKC 
phosphorylates serine residues in band 3, band 4.1 and band 4.8 (Govekar and Zingle, 2001). 
Go6976 and Go6983 are used to exclude the involvement of PKD in cell signals. Go6976 
inhibits classical isoforms of PKC and PKD, but Go6983 inhibits classical isoforms only. The 
absence of differences in the effects of Go6976 and Go6983 on the lactate formation (Table 1) 
excludes the involvement of PKD in the control of glycolysis and may indicate involvement 
of classical PKCǂ as a negative regulator of glycolysis. It was demonstrated that PKC 
translocated from the interior of erythrocytes to the membrane as a result of various stimuli 
(Govekar and Zingle, 2001). 
Go6976 (inhibitor of classic isoforms and PKD), and also PKD "switch-off" inhibitor Go6983, 
reliably activate ATPase activity. This presents PKC as a negative regulator of Na+/K+-
ATPase. The effect of stimulation with Go6976 is almost twice higher than stimulation with 
Go6983 (Table 2 and Fig.3). This probably suggests a specific function of PKD as an inhibitor 
of Na+/K+-ATPase. PKD has a catalytic domain, which shows more similarity to CaM-
dependent kinases than to PKC. PKD efficiently phosphorylated synthetic substrates of 
Ca2+/CaM -dependent kinase II, but does not catalyze phosphorylation of substrates  
 
Agents ( n = 6) Na+/K+ ATPase  [U/g. Protein] p 
No agents (control) 4.44 ±  0.98 - 
Go6976 13.04 + 2.11 <0.001 
Go6983 8.18 + 3.24 <0.05 
Caffeine 5.68 + 1.57 >0.1 
ǼA 5.18 ± 0.61 >0.1 
Calyculin A 2.71 ± 0.98 <0.02 
W-7 4.81 + 0.86 >0.1 
Table 2. Effect of modulators of phosphorylation on Na+/K+-ATPase 
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Fig. 2. Effect of modulators of phosphorylation on lactate formation (control=100%). 
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Fig. 3. Effect of modulators of phosphorylation on Na+/K+-ATPase (control=100 %) 
typical of PKC (Ron et al., 1999). CaM inhibits the sodium pump in erythrocytes (Okafor et 
al. 1997; Yingst et al. 1992), and because of similarities with the effects of CaM, PKD 
participation in erythrocyte phosphorylation could be assumed, leading to a decrease in 
activity of Na+/K+-ATPase. It is also proven an inhibitory effect of PKD on Na+/H+ - 
antiport in other cell types (Haworth and Sinnet-Smithh, 1999). It could be speculated that 
due to the antiport inhibition by PKD, the activity of Na+/K+-ATPase is being reduced.  
10.3.2 Effect of caffeine 
The mechanisms by which caffeine stimulates erythrocyte glycolysis (Table 1 and Fig.2) may 
include modulation of erythrocyte protein phosphorylation (Boivin, 1988) or changes in the 
conformation of the erythrocyte membrane proteins that facilitate the access of enzymes 
phosphorylating band 3 (Sato et al. 1990). It is known that methylxanthines are able to 
inhibit cyclic nucleotide-dependent protein kinases present in the cytosol and the 
erythrocyte membrane (Boivin, 1988). This inhibition may be due to competition for ATP 
(Boivin, 1988) and may be involved in the regulation of PK, whose active form is the 
dephosphorylated one (Kiener and Weathead, 1980; Garrillo et al., 2000; Nakashima et al., 
1982). Caffeine can exert an indirect effect on lactate formation in erythrocytes through 
stimulation of Na+/K+-ATPase (Gusev et al. 2000), but our results showed that caffeine has 
no reliable effect on the activity of erythrocyte Na+/K+-ATPase (Table 2 and Fig 3). The 
identified differences may be due to the fact that in that study, erythrocytes from Rana 
temporaria were examined (Gusev et al, 2000). 
10.3.3 Effect of protein phosphatases inhibitors 
Okadaic acid (OA) is an inhibitor of serine/treonine phosphatases (Bordin et al. 1993). The 
incentive effect of OA on glycolysis (Table 1 and Fig.2) may be indirect, as a consequence of 
activation of MAPK-dependent way that increases Na+/H+-antiport (Sartori et al. 1999). It is 
known that one of the mechanisms for glycolysis stimulation is the activation of proton 
export through this antiport (Madshus, 1988). An interesting fact is that OA and various 
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growth factors (GF), e.g. TGF and EGF, exert a stimulatory effect on Na+/H+-antiport (NHE-
1) through phosphorylation of identical serine residues in its molecule (Sardet et al. 1991). 
Calyculin A and OA are likely to cause stimulation of glycolysis by using pathways 
involving protein phosphatase type II (PP2), Table 1 and Fig 2. Protein phosphatase type I 
(PP1) is highly sensitive to calyculin A (CalA), but not to OA. Protein phosphatase type II 
(PP2) is highly sensitive to both inhibitors, CalA and OA (Bize et al. 1999). OA has no effect 
on erythrocyte sodium pump (Table 2 and Fig.3), which probably means that phosphatase 
type II (PP2) is not involved in cellular signals engaged with the control of Na+/K+-ATPase, 
but Calyculin A inhibits reliably (with about 40%) the pump activity, which may be due to 
the involvement of PP1 in cell signals leading to activation of Na+/K+-ATPase (Table2 and 
Fig.3).  
10.3.4 Effect of W-7 
As calmodulin antagonist W-7 restores reduced physiological ability of erythrocytes to 
change their shape when loaded with ǿа2+ (Murakami et al. 1986) and also exerts a 
vasodilator effect (Beresewiz, 1989). The beneficial effect of W-7 on erythrocyte rheology 
may be due to its stimulatory effect on glycolysis and improvement of erythrocyte 
bioenergetics (Table 1 and Fig.2). The stimulatory effect of W-7 on glycolysis may be due to 
blocking the inhibitory effect of calmodulin on Na+/ǻ+-antiport (Yingst et al. 1992), or to 
decrease in the processes of phosphorylation/dephosphorylation, regulated by 
ǿа2+calmodulin (Benaim and Villalobo, 2002, Corti et al. 1999). W-7 increases by 8% the 
activity of Na+/K+-ATPase but the effect lacks statistical significance (Table 2 and Fig.3) in 
the absence of Ca2+. There is evidence in the literature for an inhibitory effect of calmodulin 
on erythrocyte Na+/K+-ATPase, which occurs at 2 µM Ca2+ in the incubation medium 
(Yingst et al. 1992). The difference with our results could be explained probably with these  
specific experimental conditions. In our study, no extra ammounts of calcium were added 
into incubation medium. Erythrocytes have about 80 nM intracellular Ca2+ (Astarie et al. 
1992). Perhaps the inhibitory effect of calmodulin (resp. stimulation with W-7) on the 
sodium pump acts as a regulatory mechanism when an increase in intracellular calcium 
content is presented, and primarily affects Ca2+-binding capacity of calmodulin (Astarie et 
al. 1992). 
10.4 Conclusions  
Processes of phosphorylation-dephosphorylation of erythrocyte membrane and plasma 
proteins provide different levels of interaction, and also participate in maintaining the 
integrity of erythrocyte membrane and exerting control over important metabolic processes 
in erythrocytes. Summary of the existing data in literature shows they are more 
comprehensive in terms of the effect of primary messengers that bind to membrane 
receptors on erythrocytes and the consequent biological effects of the ligand-receptor 
interaction. Down-stream signaling pathways, though, where a major role in 
phosphorylation processes is played by protein kinases and protein phosphatases, remain 
less clear. Expansion of our knowledge and better understanding of signal transduction in 
erythrocytes will enable possible control to be exerted over their impact in maintenance of 
vascular tone, procoagulant activity and antioxidant status, erythrocyte aging, senescence, 
eryptosis (apoptosis), and erythrophagocytosis. Our results demonstrate that erythrocytes 
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use different cell signals for regulation of glycolysis and activity of the sodium pump. They 
also reveal that different classes of PKC most likely taking part in regulation of glycolysis and 
Na+/K+-ATPase. Protein phosphatase inhibitors have opposite effects in the control of 
glycolysis and sodium pump, which indicates involvement of different protein phosphatases 
in cellular signal transduction that controls ion transport and cell energetics. Caffeine and W-7 
have a reliable effect on the stimulation of glycolysis, but not on sodium pump. 
Glycolysis
Na+/K+ -ATPase
PKC -α
Go6976 
Go6983
Caffeine
Cyclic nucleotide
phosphodiesterase
PK
Band - 3
Band - 3P
OA
MAPK
Na+/H+ 
antiport
PP2
CalAW-7
CaM
Go6976
PKD CaM
-
dependent
kinase II
CalA
PP1
 
Fig. 4. Erythrocytes use different processes of phosphorylation in regulation of glycolysis 
and sodium pump.  
(A). Glycolysis. Go6976 and Go6983 are inhibitors of PKC and stimulators of glycolysis. The 
target for this effect is PKC-ǂ, which is probably a negative regulator of glycolysis. Caffeine 
increases the formation of lactate as: a) an activator of phosphodiesterase and inhibitor of 
c.AMP-dependent phosphorylation processes that keeps pyruvate kinase in dephosphorylated 
active form; b) induces conformational changes or activates phosphorylation of band 3. W-7 as 
a CaM antagonist blocks its inhibitory effect on Na+/H+-antiport, which activates glycolysis. 
Okadaic acid (OA) stimulates glycolysis as an inhibitor of protein phosphatase PP2, which is 
probably a negative regulator of glycolysis, and as a stimulator of MAPK-dependent 
phosphorylation of Na+/H+-antiport. Calyculin A (CalA) activates glycolysis as PP2 inhibitor 
that turns the proteins involved in glycolysis to their active dephosphorylated form. (B) 
Na+/K+-ATPase. PKD is likely a negative regulator of the sodium pump using CaM-
dependent pathway since its specific inhibitor Go6976 significantly increases the activity of 
Na+/K+-ATPase. Cal A inhibits the activity of the pump reliably, which may be due to the 
involvement of PP1 in cell signals leading to activation of Na+/K+-ATPase. 
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